Literature DB >> 16155376

Plasma exchange using a continuous venovenous hemofiltration machine in children.

Ewa Ciechanska1, Lauren Segal, Hubert Wong, Christine Chretien, Janusz Feber, Guido Filler.   

Abstract

BACKGROUND: There is considerable interest in using continuous venovenous hemofiltration machines for plasma exchange therapy in children.
METHODS: Retrospective study of 7 patients and 61 plasma exchange treatments using the Baxter/Edwards Lifesciences BM25 machine with commercially available plasma filters (mostly Asahi Plasmaflo).
RESULTS: The average total exchange volume was 1.5 times the plasma volume, achieved at a blood flow rate of 100 ml/m(2) (3.5 ml/kg/min) and a turnover rate of 25 ml/kg/h over a 3-hour duration. Fifty-six percent of the time, a mean heparin bolus of 29 units/kg resulted in subtherapeutic activated clotting times. Mean heparin infusion rates of 35 units of heparin/kg/h achieved effective anticoagulation. A calcium infusion rate of 0.11 +/- 0.05 mmol/kg/h avoided hypocalcemia. One patient experienced the serious complication of membrane reaction.
CONCLUSIONS: This setup provides a safe approach to plasma exchange in children. A similar method could be implemented in other centers. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16155376     DOI: 10.1159/000088215

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

Review 1.  Tandem hemodialysis and plasma exchange.

Authors:  Guido Filler; William F Clark; Shih-Han S Huang
Journal:  Pediatr Nephrol       Date:  2013-09-11       Impact factor: 3.714

Review 2.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

3.  Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.

Authors:  Megha Suri; Kim Tran; Ajay P Sharma; Guido Filler; Joanne Grimmer
Journal:  Int Urol Nephrol       Date:  2008-05-20       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.